CCM
PCRX icon

CAAS Capital Management’s Pacira BioSciences PCRX Stock Holding History

CAAS Capital Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-13,000
Closed -$502K – 482
2022
Q4 		$502K Buy
+13,000
New +$502K 0.03% 190